COVAX – Time to reconsider the strategy and its target

Bell, David A.; Brown, Garrett Wallace; Oyibo, Wellington; Ouédraogo, Samiratou; Tacheva, Blagovesta; Barbaud, Elena; Kalk, Andreas; Ridde, Valéry; Paul, Élisabeth

doi:10.1016/j.hpopen.2023.100096

Cited by 4 publications

(3 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Through a combination of vaccine delivery strategies, programs have achieved impressive vaccination goals on a massive scale in a short timeframe, but this has come at the cost of the diversion of resources from other health services and burnout among healthcare workers [ 44 , 45 ]. The current evidence on the waning of natural and vaccine immunity provides reason to believe that periodic booster doses for vulnerable populations will be needed.…”

Section: Discussionmentioning

confidence: 99%

Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review

Nabia,

Wonodi,

Vilajeliu

et al. 2023

Vaccines

View full text Add to dashboard Cite

The COVID-19 vaccination is a crucial public health intervention for controlling the spread and severity of the SARS-CoV2 virus. COVID-19 vaccines have been developed in record time, but their deployment has varied across countries, owing to differences in health system capacity, demand for the vaccine, and purchasing power of countries. The aim of this rapid review is to summarize and synthesize experiences on COVID-19 vaccine service delivery and integration to inform future COVID-19 vaccination programming and contribute to the knowledge base for future pandemic management. A systematic search was conducted in PubMed, Scopus, and Global Index Medicus databases. Twenty-five studies were included in the analysis. Included studies spanned nine countries where COVID-19 vaccines were delivered through mass, mobile, and fixed-post vaccination service delivery models. There was limited evidence of integrating COVID-19 vaccines into routine services for pregnant women, people who inject drugs, and leveraging existing health programs to deliver COVID-19 vaccines to the general population. Common challenges reported were vaccine skepticism, lack of adequate health workers, and linguistic barriers to access. Partnerships with a variety of stakeholders and the involvement of volunteers were vital in overcoming barriers and contributed to the efficient functioning of COVID-19 vaccination programs.

show abstract

Section: Discussionmentioning

confidence: 99%

Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review

Nabia,

Wonodi,

Vilajeliu

et al. 2023

Vaccines

View full text Add to dashboard Cite

show abstract

“…Local governments tried to source vaccines through the COVID-19 Tools Accelerator (ACT-A), and mainly its vaccine column named COVAX, which involved political and financial collaboration between donors, the WHO, Gavi The Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and the United Nations Children's Fund (UNICEF). As part of COVAX, the global public health community, led by the WHO, established an 'ambitious' objective: to vaccinate at least 70% of the population in low-and middle-income countries (LMICs) against COVID-19, including those in sub-Saharan Africa (Bell et al, 2023;CEPAL, 2022).…”

Section: Latin American Macro Environment and Pharmaceutical Industry...mentioning

confidence: 99%

Drugmex, the Family-Owned Company Which Delivered the First COVID-19 Vaccine to Mexico

Igoe,

Delaney,

Mireles

2023

Attaining the 2030 Sustainable Development Goal of Good Health and Well-Being

View full text Add to dashboard Cite

“…It is the continent with the lowest vaccination levels: just 30% of people have received a complete initial protocol 3. Covax, established to guarantee equitable global access to vaccines,4 was disrupted by funding shortfalls, “vaccine nationalism,” and hoarding by richer countries 56…”

mentioning

confidence: 99%